These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13433378)

  • 41. [Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen].
    Huisman IA; Stegeman CA; Gans RO; Gansevoort RT
    Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2329-33. PubMed ID: 16261711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contrast-induced nephropathy.
    McCullough PA; Soman SS
    Crit Care Clin; 2005 Apr; 21(2):261-80. PubMed ID: 15781162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gadolinium-induced nephrotoxicity.
    Buhaescu I; Izzedine H
    Int J Clin Pract; 2008 Jul; 62(7):1113-8. PubMed ID: 18218006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contrast-induced nephropathy as an indicator of diffuse endothelial dysfunction: introducing novel therapeutic options for decreasing the long-term mortality.
    Ardalan MR; Rastegar A; Tubbs RS; Shoja MM
    Med Hypotheses; 2007; 69(4):961-2. PubMed ID: 17367955
    [No Abstract]   [Full Text] [Related]  

  • 45. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pathophysiology of contrast-induced nephropathy].
    Guastoni C; De Servi S
    G Ital Cardiol (Rome); 2009 Feb; 10(2):73-8. PubMed ID: 19348143
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contrast-induced nephropathy: the wheel has turned 360 degrees.
    Thomsen HS; Morcos SK; Barrett BJ
    Acta Radiol; 2008 Jul; 49(6):646-57. PubMed ID: 18568557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gadolinium-based contrast media and the development of nephrogenic systemic fibrosis in patients with renal insufficiency.
    Chewning RH; Murphy KJ
    J Vasc Interv Radiol; 2007 Mar; 18(3):331-3. PubMed ID: 17377176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New pharmacological protocols to prevent or reduce contrast media nephropathy.
    Briguori C; Airoldi F; Morici N; Colombo A
    Minerva Cardioangiol; 2005 Feb; 53(1):49-58. PubMed ID: 15788979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute kidney injury with iodinated contrast.
    McCullough PA
    Crit Care Med; 2008 Apr; 36(4 Suppl):S204-11. PubMed ID: 18382195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental evaluation of the toxicity of hypaque, urokon, and thorotrast incident to their use as aortographic contrast media.
    KILLEN DA; LANCE EM; OWENS G
    Surg Forum; 1958; 9():337-9. PubMed ID: 13635385
    [No Abstract]   [Full Text] [Related]  

  • 52. Nephrogenic systemic fibrosis: an overview.
    Cowper SE
    J Am Coll Radiol; 2008 Jan; 5(1):23-8. PubMed ID: 18180005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Translumbar Aortography: A Simple, Safe, Technic.
    Beall AC; Henly WS; Morris GC; Crawford ES; Cooley DA; Debakey ME
    Ann Surg; 1963 Jun; 157(6):882-91. PubMed ID: 17859740
    [No Abstract]   [Full Text] [Related]  

  • 54. Unilateral renal damage after translumbar a ortography.
    PIGEON G; LEFEBVRE R; CARTIER GE; GENEST J
    Can Med Assoc J; 1960 Jul; 83(2):69-72. PubMed ID: 14432940
    [No Abstract]   [Full Text] [Related]  

  • 55. Anatomical studies of the lumbar arteries: with reference to the safety of translumbar aortography.
    LAUFMAN H; BERGGREN RE; FINLEY T; ANSON BJ
    Ann Surg; 1960 Oct; 152(4):621-34. PubMed ID: 13759435
    [No Abstract]   [Full Text] [Related]  

  • 56. Aortography and peripheral arteriography: an analysis of results in a university medical center.
    FOSTER JH; KILLEN DA
    Ann Surg; 1959 Mar; 149(3):321-41. PubMed ID: 13627990
    [No Abstract]   [Full Text] [Related]  

  • 57. Contrast media and the kidney.
    Br Med J; 1971 Apr; 2(5752):4-5. PubMed ID: 5550884
    [No Abstract]   [Full Text] [Related]  

  • 58. Hyperhydration: a method of decreasing the nephrotoxic effects of Urokon as employed in aortography.
    MORRIS GC; CRAWFORD ES; BEALL AC; MOYER JH
    Surg Forum; 1957; 7():319-22. PubMed ID: 13433378
    [No Abstract]   [Full Text] [Related]  

  • 59. Complication of aortography; factors influencing renal function following aoriography with 70 per cent urokon.
    BEALL AC; CRAWFORD ES; COUVES CM; DEBAKEY ME; MOYER JH
    Surgery; 1958 Mar; 43(3):364-80. PubMed ID: 13647159
    [No Abstract]   [Full Text] [Related]  

  • 60. Relative suitability of urokon 70 per cent and hypaque 90 per cent for use as aortographic contrast media.
    KILLEN DA; LANCE EM; OWENS G
    Surgery; 1959 Mar; 45(3):436-44. PubMed ID: 13635221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.